The US Food and Drug Administration announced Wednesday that it is requesting manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately. The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over…
Updated: